— Know what they know.
Not Investment Advice
Also trades as: IMMNOV.ST (STO) · $vol 0M · 0G8X.L (LSE) · $vol 0M

IMMVF OTC

Immunovia AB
1W: +0.0% 1M: -50.0% 3M: -50.0% YTD: -50.0% 1Y: -80.8% 3Y: -99.1% 5Y: -99.8%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Sell · Power 26 · $3.1M mcap · 296M float · 0.0001% daily turnover

Balance Sheet Trends

Total Assets
$88M +166.3% ▲
5Y CAGR: -33.2%
Total Liabilities
$23M +9.5% ▲
5Y CAGR: -17.6%
Shareholders Equity
$65M +454.3% ▲
5Y CAGR: -36.0%
Cash & Investments
$77M +205.2% ▲
5Y CAGR: -30.3%
Total Debt
$855K +25.7% ▲
5Y CAGR: -51.9%
Net Debt
-$76M -210.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$287M$106M$77M$25M$77M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$287M$106M$77M$25M$77M
Net Receivables$494K$348K$146K$3M$3M
Inventory$2M$2M$0$0$119K
Other Current Assets$4M$3M$1M$0$19
Total Current Assets$297M$116M$81M$29M$80M
Property, Plant & Equip.$47M$48M$15M$2M$963K
Goodwill & Intangibles$147M$134M$3M$2M$7M
Long-Term Investments$334K$334K$0$0$127K
Other Non-Current Assets$599K$3M$506K$553K$0
Total Non-Current Assets$197M$185M$18M$4M$8M
Total Assets$494M$301M$99M$33M$88M
— Liabilities —
Accounts Payable$3M$2M$8M$875K$0
Short-Term Debt$0$0$0$0$0
Deferred Revenue$20M$15M$0$0$0
Other Current Liabilities-$17M-$13M$4M$14M$23M
Total Current Liabilities$33M$24M$30M$16M$23M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$6M$0
Total Non-Current Liabilities$27M$33M$2M$6M$0
Total Liabilities$60M$57M$32M$21M$23M
— Equity —
Common Stock$1M$1M$2M$5M$20M
Retained Earnings-$581M-$749M-$1.1B-$1.1B-$1.3B
Accumulated OCI$0-$24M$0-$44M$17M
Total Stockholders Equity$434M$244M$67M$12M$65M
Total Liabilities & Equity$494M$301M$99M$33M$88M
— Key Metrics —
Total Debt$33M$38M$4M$680K$855K
Net Debt-$254M-$68M-$73M-$25M-$76M
Total Investments$334K$334K$0$0$127K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms